Drug intelligence / Profile preview

Tianxia Capsule

Development stage: Preclinical
Lead developer: Lei Yun Shang
Administration: Oral

Overview

Tianxia Capsule is a Traditional Chinese Medicine (TCM) formulation currently in the research and development pipeline of Lei Yun Shang, a prominent Chinese pharmaceutical company specializing in traditional therapies. The product is an oral capsule composed of a proprietary blend of herbal ingredients. As a TCM product, it is designed to work through a multi-component, multi-target approach to restore physiological balance, rather than targeting a single molecular pathway. While specific clinical indications and molecular targets are not publicly disclosed in standard Western pharmacological formats, it is part of Lei Yun Shang's portfolio of modernized TCM products undergoing scientific evaluation.

Brand names: Tianxia Capsule
Other names: 天下胶囊Tianxia Jiaonang

Targets

PXR (Pregnane X receptor)

Beyond the preview

Go deeper on Tianxia Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tianxia Capsule.

Explore the full profile